Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Neuer Top-Geologe an Bord - zündet jetzt die nächste Kursrakete?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Edison Investment Research

ZeitAktuelle NachrichtenRatingLeser
MiBraemar - Revised 2030 strategy for growth156Braemar has successfully grown underlying group revenue by c 10% per year since 2013 and the new growth strategy outlines initiatives and targets that are designed to continue top-line growth and improve...
► Artikel lesen
MiFranklin Global Trust - An exciting new chapter in the trust's life177Franklin Global Trust (FRGT) was formerly the Martin Currie Global Portfolio Trust. Since October 2018 it has been managed by Zehrid Osmani, who is head of Franklin Templeton's Edinburgh-based Global...
► Artikel lesen
MiChesterfield Special Cylinders - Green shoots from a refocused business165Following the disposal of its Precision Machined Components (PMC) division, Chesterfield Special Cylinders (CSC) is moving forward as a focused, specialist high-pressure cylinder business, as reflected...
► Artikel lesen
DiAFT Pharmaceuticals - Setting the stage for sustained long-term growth204AFT Pharmaceuticals reported FY25 revenues of N Z$208m, posting a strong recovery in H2, with dissipating headwinds and traditional H2 seasonality offsetting the softer H1 performance. H225 revenues...
► Artikel lesen
DiIntralot - Strong underlying revenue growth in Q125161Intralot has enjoyed a strong start to the year with c 11% growth, albeit EBITDA was broadly flat as the growth came from its lowest margin businesses. Although there is no explicit financial guidance...
► Artikel lesen
DiOSE Immunotherapeutics - ASCO 2025 update showcases Tedopi potential186OSE Immunotherapeutics presented multiple updates at the 61st Annual American Society of Clinical Oncology Conference (ASCO 2025) related to Tedopi, its proprietary off-the-shelf neoepitope-based cancer...
► Artikel lesen
DiCI Games - Operational and product inflection point207During 2025 (a year with no major releases), CI Games is refining its business model and in the process is also helping to re-define the soulslike genre. We believe that management's latest player-centric...
► Artikel lesen
DiFiltronic - New contract with Leonardo318Filtronic has won a new contract with Leonardo, its lead defence customer, worth £0.8m. The contract is to supply high-performance modules for airborne radar applications and is expected to ship in...
► Artikel lesen
DiSareum Holdings - A decisive step towards Phase II169Sareum Holdings has reported the initiation of toxicology studies required ahead of the Phase II studies for its lead TYK2/JAK1 asset, SDC-1801. We view this as a key milestone in SDC-1801's development...
► Artikel lesen
MoCordel Group - US Class 1 win for capture, analytics and PTC175Cordel Group has announced the signing of a new Class 1 freight railroad operator, marking a significant step forward in the company's US growth strategy and its ambitions in Positive Train Control...
► Artikel lesen
MoMendus - Another encouraging ovarian cancer update123Mendus presented a positive clinical update for its Phase I ALISON trial in ovarian cancer at the 61st Annual American Society of Clinical Oncology conference (ASCO 2025). Importantly, the data demonstrated...
► Artikel lesen
MoInnovation Agritech Group - Growing smarter next-generation farming153Innovation Agritech Group (IAG) is a UK firm listed on the JP Jenkins share-matching platform. IAG is a technology provider in the global market for vertical farming using its patented modular aeroponic...
► Artikel lesen
MoOPAP - Sports and lottery success in Q125281While OPAP's Q125 results include some favourable one-offs, the highest-ever lottery jackpot and operator-friendly results in sports betting, there is a clear message of growing market share in non-exclusive...
► Artikel lesen
29.05.Global Fashion Group - Refined and redefined403Global Fashion Group (GFG) operates leading fashion and lifestyle platforms that enable brands to reach customers in a mix of developed and developing markets with high growth potential. Management...
► Artikel lesen
29.05.Immix Biopharma - Positive newsflow continues for NEXICART-2297Immix Biopharma has announced a positive clinical update for the US-based Phase I/II NEXICART-2 trial, investigating lead CAR-T candidate NXC-201 as a potential treatment for relapsed/refractory (r/r)...
► Artikel lesen
28.05.Rockwood Strategic - Different approach has favourable outcomes207Rockwood Strategic (RKW) is managed by Richard Staveley at Harwood Capital. He has a differentiated approach, aiming to generate a 15% annual internal rate of return (IRR) over a rolling five-year period...
► Artikel lesen
27.05.Cereno Scientific - Firing on all cylinders238In Q125, Cereno made tangible progress across both its clinical programmes. The period opened with new data for lead asset CS1 indicating disease-modifying signals, and was capped by FDA endorsement...
► Artikel lesen
27.05.Datatec - Strong performance drives increased dividend payout policy286Datatec reported a strong set of results for FY25, with gross profit, adjusted EBITDA and underlying EPS all ahead of our forecasts. All three divisions reported strong growth in adjusted EBITDA, highlighting...
► Artikel lesen
27.05.Alphamin Resources - Honing FY25 forecasts303Notwithstanding press headlines reading 'Alphamin Resources profit slumps in first quarter on DRC disruptions', the company's Q125 results were universally better than in Q124 and consistent with its...
► Artikel lesen
27.05.Alkane Resources - On the road to Mandalay309Since our last note on the company, Alkane Resources has announced its interim results, its Q325 quarterly activities report and, on 28 April, a merger of equals with Canada's Mandalay Resources Corporation....
► Artikel lesen
27.05.Kainos Group - Green shoots of growth256After a tough year, Kainos is seeing signs of improving demand, with Q425 revenue returning to growth. Workday Products continues to be the main growth driver and in Digital Services, the company should...
► Artikel lesen
27.05.Creo Medical - Rightsized and refocused220Creo Medical's FY24 results unveiled a streamlined business model focused on its core advanced energy platform, following the divestment of a 51% stake in its consumables arm, Creo Medical Europe (CME...
► Artikel lesen
23.05.The Platform Group - Strong momentum in Q125485The Platform Group's Q125 results show strong momentum with a seasonally high adjusted EBITDA margin. Coming so soon after the recent FY24 results, there is no change to management's guidance for the...
► Artikel lesen
23.05.Smiths News - New recycling MD underpins new activity potential293Smiths News' PBT increased by 11% in H125, a combination of higher profits and lower financing costs as both debt and debt margins declined. However, in addition to this and perhaps more exciting is...
► Artikel lesen
23.05.Games Workshop Group - Strong core in Q425447Games Workshop Group's year-end (2025) trading update shows a better Q4 than we expected, notably in its core business with high operational gearing. Licensing revenue and profit are broadly in line...
► Artikel lesen